Table 2: Overview of EPR, economic variables and the median of scaled ranks

C.	EPR (Y/N)a	GDP per capita in EURO 2006b	TPE per capita in EURO PPPa 20062, b	Pharmaceutical empl. Industry per 100,000c	Median of scaled ranks
AT	Y	31,067	413	127	0.64
BE	Y	30,187	469	281	0.42
DE	N	28,184	416	129	0.71
DK	N	21,145	246	313	0.84
EL	Y	19,123	503	121	0.26
ES	Y	22,291	453	92	0.33
FI	Y	31,709	327	114	0.64
FR	Y	28,601	475	169	0.50
IT1	Y	25,419	443	119	0.23
NL	Y	33,031	351	98	0.52
NO	Y	41,346	327	99	0.50
PT	Y	14,684	391	97	0.33
SE	N	29,025	365	173	0.46
SK	Y	23,797	330	37	0.54

AT = Austria, BE = Belgium, C. = country, DE = Germany, DK = Denmark, empl. = employment, EPR = External price referencing, EL = Greece, ES = Spain, FI = Finland, FR = France, GDP = Gross Domestic Product, IT = Italy, n.a. = not available, NL = Netherlands, NO = Norway, PE = Pharmaceutical Expenditure, PPPa = Purchasing Power Parities adjusted, PT = Portugal, SE = Sweden, SK = Slovak Republic, TPE = Total Pharmaceutical Expenditure

¹ Italy: EPR is only an additional pricing policy complementing negotiations between the manufacturer and the Medicines Agency

² TPE for the Netherlands and Norway as of 2007